BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32053940)

  • 1. The MICELI (MICrofluidic, ELectrical, Impedance): Prototyping a Point-of-Care Impedance Platelet Aggregometer.
    Roka-Moiia Y; Bozzi S; Ferrari C; Mantica G; Dimasi A; Rasponi M; Santoleri A; Scavone M; Consolo F; Cattaneo M; Slepian MJ; Redaelli A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32053940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrical impedance vs. light transmission aggregometry: Testing platelet reactivity to antiplatelet drugs using the MICELI POC impedance aggregometer as compared to a commercial predecessor.
    Mencarini T; Roka-Moiia Y; Bozzi S; Redaelli A; Slepian MJ
    Thromb Res; 2021 Aug; 204():66-75. PubMed ID: 34147831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
    Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of platelet aggregation in ovine blood using a new impedance aggregometer.
    Baumgarten A; Wilhelmi M; Kalbantner K; Ganter M; Mischke R
    Vet Clin Pathol; 2010 Jun; 39(2):149-56. PubMed ID: 20003029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry.
    Albanyan A; Al-Musa A; AlNounou R; Al Zahrani H; Nasr R; AlJefri A; Saleh M; Malik A; Masmali H; Owaidah T
    Int J Lab Hematol; 2015 Aug; 37(4):503-8. PubMed ID: 25537026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet function in baboons and humans - A comparative study of whole blood using impedance platelet aggregometry (Multiplate®).
    Ponschab M; van Griensven M; Heitmeier S; Laux V; Schlimp CJ; Calatzis A; Bahrami S; Redl H; Schöchl H
    Thromb Res; 2016 Nov; 147():115-121. PubMed ID: 27736703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new platelet function analyzer in cardiac surgery: a comparison of modified thromboelastography and whole-blood aggregometry.
    Mengistu AM; Wolf MW; Boldt J; Röhm KD; Lang J; Piper SN
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):40-6. PubMed ID: 18249329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplate whole blood impedance point of care aggregometry: preliminary reference values in healthy infants, children and adolescents.
    Halimeh S; Angelis Gd; Sander A; Edelbusch C; Rott H; Thedieck S; Mesters R; Schlegel N; Nowak-Göttl U
    Klin Padiatr; 2010 May; 222(3):158-63. PubMed ID: 20514620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole Blood Platelet Aggregometry.
    Fritsma GA; McGlasson DL
    Methods Mol Biol; 2017; 1646():333-347. PubMed ID: 28804840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood.
    Tóth O; Calatzis A; Penz S; Losonczy H; Siess W
    Thromb Haemost; 2006 Dec; 96(6):781-8. PubMed ID: 17139373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of whole blood aggregometer to detect platelet hyperaggregability.
    Abbate R; Boddi M; Prisco D; Gensini GF
    Am J Clin Pathol; 1989 Feb; 91(2):159-64. PubMed ID: 2916459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of platelet function in dogs using a novel impedance aggregometer.
    Kalbantner K; Baumgarten A; Mischke R
    Vet J; 2010 Aug; 185(2):144-51. PubMed ID: 19879171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ex vivo anticoagulants on whole blood platelet aggregation.
    Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA
    Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy.
    Paniccia R; Antonucci E; Maggini N; Romano E; Gori AM; Marcucci R; Prisco D; Abbate R
    Am J Clin Pathol; 2009 Jun; 131(6):834-42. PubMed ID: 19461090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry.
    Stellbaum C; Ayral Y; Morguet A; Schultheiss HP; Rauch U
    Cardiovasc Revasc Med; 2012; 13(3):159-66. PubMed ID: 22503564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electric impedance platelet aggregometry in cardiac surgery patients: A comparative study of two technologies.
    Ranucci M; Baryshnikova E; Crapelli GB; Ranucci M; Meloni S; Pistuddi V;
    Platelets; 2016; 27(3):185-90. PubMed ID: 26270439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia.
    Awidi A; Maqablah A; Dweik M; Bsoul N; Abu-Khader A
    Platelets; 2009 Aug; 20(5):297-301. PubMed ID: 19548178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
    Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
    Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the magnetic field of a magnetic stirrer in an optical aggregometer affect concurrent platelet aggregation?
    Sagdilek E; Sebik O; Celebi G
    Bioelectromagnetics; 2013 Jul; 34(5):349-57. PubMed ID: 23436227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy.
    Mascelli MA; Worley S; Veriabo NJ; Lance ET; Mack S; Schaible T; Weisman HF; Jordan RE
    Circulation; 1997 Dec; 96(11):3860-6. PubMed ID: 9403608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.